U.S. federal trademark · Serial No. 85542026
Pharmaceutical preparations for new drug or the re-formation of existing drugs for use in the reversal of anticoagulation and hemostasis, to treat stroke, traumatic brain injury, hypoxia and cardiac arrest, for use as a neuroprotectant, to treat metabolic disorders, to treat hypoglycemia and hyperglycemia, to treat allergic responses and autoimmune disorders; Pharmaceutical preparations for new drug or the re-formation of existing drugs for use in chemotherapy, dermatology and urology
Development of pharmaceutical preparations and medicines for the reversal of anticoagulation and hemostasis, to treat stroke, traumatic brain injury, hypoxia and cardiac arrest, for use as neuroprotectant, to treat hypoglycemia and hyperglycemia, to treat allergic responses and autoimmune disorders, chemotherapy, dermatology, and urology; Pharmaceutical drug development services for drugs for the reversal of anticoagulation and hemostasis, to treat stroke, traumatic brain injury, hypoxia and cardiac arrest, for use as neuroprotectant, to treat hypoglycemia and hyperglycemia, to treat allergic responses and autoimmune disorders, chemotherapy, dermatology, and urology; Pharmaceutical research and development of drugs for the reversal of anticoagulation and hemostasis, to treat stroke, traumatic brain injury, hypoxia and cardiac arrest, for use as neuroprotectant, to treat hypoglycemia and hyperglycemia, to treat allergic responses and autoimmune disorders, chemotherapy, dermatology, and urology
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.